BioValid: Serpro technology for the generation of temporary biometric tokens.

BioValid is a technology developed by Serpro to generate temporary tokens from biometric data. The validation of facial biometrics and proof of life dispense with the physical presence of the citizen and the authentication of identity is done online. The Commercial Boards will already be able to use this solution and develop an entire process of opening a company in a digital way - and the identity validation, with consultation to official databases, can be done without a physical token, all by cell phone or other mobile device.

Biovalid enables the so-called “proof of life”, using a technology that involves artificial intelligence. Functionality is important to prevent one person from photographing another's photo, for example, to try to prove identity by the application.

How it works?

To increase the security of the transaction, Biovalid requests that you initially take a photo on the spot, from the instructions of the application installed on the cell phone to verify that it is you who are, at that moment, requesting identity validation. A kind of online authentication, which brings security to everyone involved.

Born in the LGPD

Another important feature of Biovalid is its adaptation to the principles of the General Data Protection Law (LGPD). Each validation request is accompanied by an authorization request for the use of data in the verification operation. And all authentication transactions are stored. Thus, it is possible to consult the Biovalid database to verify who requested a service, ensuring, with this traceability, an even greater degree of security for users.

To be able to offer the service to its users, the entity or company must subscribe to the service developed by Serpro, charged based on the volume of use in a given period (number "x" of consultations per month, for example). For the entrepreneur, citizen, user, in general, of an entity that uses a validator developed by Serpro, it is enough to download the Biovalid application on his device.